Trial intelligence / Profile preview

Perioperative Treprostinil in Pediatric Fontan Operation

NCT02498444Terminated

Sponsor
Stanford University
Start
Sep 2015
Primary completion
Dec 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of treprostinil in single ventricle heart defect (SV) (2 arms), sponsored by Stanford University. Primary endpoint: Duration of Chest Tube Drainage. Started Sep 2015; status: terminated.

02

Drugs

treprostinil
03

Conditions

single ventricle heart defect (SV)

Beyond the preview

Go deeper on NCT02498444.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02498444.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call